Selectis HEALTH, Inc. (GBCS) intrinsic value & 10-year financials
Selectis HEALTH, Inc. (GBCS) has a Graham intrinsic value of $3.65 per share. Over the last 10 fiscal years revenue grew 34.6% a year to $41.4M, with an average return on invested capital of -5.2%.
- Graham intrinsic value
- $3.65
- Revenue (FY2025)
- $41.4M
- Revenue growth (10-yr CAGR)
- 34.6%
- ROIC (10-yr avg)
- -5.2%
- Free cash flow (FY2025)
- $1.4M
GBCS 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $41.4M | -$1.0M | -$0.34 | $1.4M | -3.8% | -7.5% |
| FY2024 | $39.5M | -$2.4M | -$0.80 | -$1.9M | -6.9% | -8.6% |
| FY2023 | $36.8M | -$4.0M | -$1.31 | $506.9K | -24.4% | -11.7% |
| FY2022 | $40.6M | -$2.4M | -$0.79 | -$527.5K | -0.7% | -6.6% |
| FY2021 | $29.3M | -$2.3M | -$0.82 | -$790.5K | -2.5% | -6.0% |
| FY2020 | $20.9M | $3.0M | $0.11 | $1.7M | 16.1% | 7.8% |
| FY2019 | $6.9M | -$861.6K | -$0.03 | -$799.9K | 18.8% | -2.3% |
| FY2018 | $3.6M | -$2.0M | -$0.08 | -$655.1K | 13.1% | -5.4% |
| FY2017 | $3.1M | -$3.0M | -$0.12 | -$642.1K | 14.8% | -8.1% |
| FY2016 | $2.9M | -$1.2M | -$0.05 | -$820.6K | -2.0% | -3.2% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
SELECTIS HEALTH, INC. is a consistent compounder, expanding top-line revenue at 34.6% annually over the past decade.
SELECTIS HEALTH, INC. has historically struggled to out-earn its cost of capital, averaging just -5.2% ROIC.
Over the decade, SELECTIS HEALTH, INC. shows that management has aggressively returned capital to shareholders by retiring 86.9% of outstanding shares.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, SELECTIS HEALTH, INC. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $3.65 per share.